Granite Bio AG

Swiss Biotech Association

Member

Biotech in the Autoimmune/Fibrosis Therapeutics Space

+41 79 352 54 28
dhartl@granitebio.com
Dominik Hartl, MD

Location

Aeschenvorstadt 36, 4051 Basel, Switzerland

Facts & figures

Type of organization

Private company
Year of foundation

2020
Number of employees in Switzerland

1-9

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

plusbiome AG

plusbiome AG is a Swiss startup company working at the interface of digital health and the microbiome. We design and market customised probiotics that truly support customers and their well-being,. Customers also profit from accompanying Apps.
4057 Basel

SOMAGENETIX AG

Somagenetix is a Spin-off from the Univ of Zurich leveraging scientific, clinical and commercial expertise to solve unmet medical needs through gene therapy. We aim at becoming a leading gene therapy company with first-in-class and best-in-class treatment for phagocyte-related disorders.
8047 Zürich

Adoram Therapeutics SA

Adoram Therapeutics is developing a suite of small molecule allosteric modulators for different indications. Our primary asset in the preclinical stage, is a negative allosteric modulator (NAM) of a clinically validated immuno-oncology target - the adenosine 2A receptor (A2AR).
1212 Grand-Lancy